Login
Home
Charts
Search
Watchlist
Products

Sheel Biotech Ltd

SHEEL·NSE
₹58.00-3.33%Tue, 22 Sept '26 15:11
Industry:Floriculture/Tissue Culture
Indices:

Sheel Biotech Ltd

SHEEL
NSE
₹58.00
-3.33%
|Tue, 22 Sept '26 15:11
SOICxStockScans Reports
Industry
Floriculture/Tissue Culture
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹118Cr
Close
Close Price
₹58.00
Industry
Industry
Floriculture/Tissue Culture
PE
Price To Earnings
10.21
PS
Price To Sales
1.07
Revenue
Revenue
₹110Cr
Rev Gr TTM
Revenue Growth TTM
8.12%
PAT Gr TTM
PAT Growth TTM
9.29%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
11902288
Growth YoY
Revenue Growth YoY%
93.7-2.5
Expenses
ExpensesCr
14732074
Operating Profit
Operating ProfitCr
-217215
OPM
OPM%
-21.919.38.116.5
Other Income
Other IncomeCr
0001
Interest Expense
Interest ExpenseCr
1111
Depreciation
DepreciationCr
0011
PBT
PBTCr
-317114
Tax
TaxCr
0202
PAT
PATCr
-415012
Growth YoY
PAT Growth YoY%
105.0-20.4
NPM
NPM%
-33.516.10.913.1
EPS
EPS₹
0.00.00.05.7
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
11902288
Growth YoY
Revenue Growth YoY%
93.7-2.5
Expenses
ExpensesCr
14732074
Operating Profit
Operating ProfitCr
-217215
OPM
OPM%
-21.919.38.116.5
Other Income
Other IncomeCr
0001
Interest Expense
Interest ExpenseCr
1111
Depreciation
DepreciationCr
0011
PBT
PBTCr
-317114
Tax
TaxCr
0202
PAT
PATCr
-415012
Growth YoY
PAT Growth YoY%
105.0-20.4
NPM
NPM%
-33.516.10.913.1
EPS
EPS₹
0.00.00.05.7

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
63718092102110
Growth
Revenue Growth%
12.213.315.210.38.1
Expenses
ExpensesCr
576471788794
Operating Profit
Operating ProfitCr
769141516
OPM
OPM%
10.39.011.015.714.714.8
Other Income
Other IncomeCr
00001
Interest Expense
Interest ExpenseCr
112122
Depreciation
DepreciationCr
111111
PBT
PBTCr
556121314
Tax
TaxCr
001222
PAT
PATCr
555101112
Growth
PAT Growth%
-6.012.6106.31.510.6
NPM
NPM%
7.66.46.311.310.410.7
EPS
EPS₹
11.63.13.57.27.26.7
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
63718092102110
Growth
Revenue Growth%
12.213.315.210.38.1
Expenses
ExpensesCr
576471788794
Operating Profit
Operating ProfitCr
769141516
OPM
OPM%
10.39.011.015.714.714.8
Other Income
Other IncomeCr
00001
Interest Expense
Interest ExpenseCr
112122
Depreciation
DepreciationCr
111111
PBT
PBTCr
556121314
Tax
TaxCr
001222
PAT
PATCr
555101112
Growth
PAT Growth%
-6.012.6106.31.510.6
NPM
NPM%
7.66.46.311.310.410.7
EPS
EPS₹
11.63.13.57.27.26.7

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
444415
Reserves
ReservesCr
5356596969
Current Liabilities
Current LiabilitiesCr
1320212324
Non Current Liabilities
Non Current LiabilitiesCr
121410115
Total Liabilities
Total LiabilitiesCr
829394106113
Current Assets
Current AssetsCr
74838395101
Non Current Assets
Non Current AssetsCr
810111112
Total Assets
Total AssetsCr
829394106113
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
444415
Reserves
ReservesCr
5356596969
Current Liabilities
Current LiabilitiesCr
1320212324
Non Current Liabilities
Non Current LiabilitiesCr
121410115
Total Liabilities
Total LiabilitiesCr
829394106113
Current Assets
Current AssetsCr
74838395101
Non Current Assets
Non Current AssetsCr
810111112
Total Assets
Total AssetsCr
829394106113

Cash Flow

Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
29-19-18
Investing Cash Flow
Investing Cash FlowCr
-2-20-2-7
Financing Cash Flow
Financing Cash FlowCr
0-72-726
Net Cash Flow
Net Cash FlowCr
00002
Free Cash Flow
Free Cash FlowCr
18-18
CFO To PAT
CFO To PAT%
48.6183.0-8.886.6-149.4
CFO To EBITDA
CFO To EBITDA%
34.3105.3-6.461.5-107.9
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
29-19-18
Investing Cash Flow
Investing Cash FlowCr
-2-20-2-7
Financing Cash Flow
Financing Cash FlowCr
0-72-726
Net Cash Flow
Net Cash FlowCr
00002
Free Cash Flow
Free Cash FlowCr
18-18
CFO To PAT
CFO To PAT%
48.6183.0-8.886.6-149.4
CFO To EBITDA
CFO To EBITDA%
34.3105.3-6.461.5-107.9

Ratios

Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
81118
Price To Earnings
Price To Earnings
6.910.2
Price To Sales
Price To Sales
0.71.1
Price To Book
Price To Book
0.60.9
EV To EBITDA
EV To EBITDA
7.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.533.333.838.336.0
OPM
OPM%
10.39.011.015.714.714.814.8
NPM
NPM%
7.66.46.311.310.410.710.7
ROCE
ROCE%
7.76.99.514.314.4
ROE
ROE%
8.57.58.014.412.7
ROA
ROA%
5.84.85.49.99.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
81118
Price To Earnings
Price To Earnings
6.910.2
Price To Sales
Price To Sales
0.71.1
Price To Book
Price To Book
0.60.9
EV To EBITDA
EV To EBITDA
7.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.533.333.838.336.0
OPM
OPM%
10.39.011.015.714.714.814.8
NPM
NPM%
7.66.46.311.310.410.710.7
ROCE
ROCE%
7.76.99.514.314.4
ROE
ROE%
8.57.58.014.412.7
ROA
ROA%
5.84.85.49.99.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Sheel Biotech Ltd

  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/dj55kcp8cq1wj99h5ojmktua.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/1ipirjogcd4mfir2vnfzpwbr.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/f3bveqf8ay72vu8lk77mnxiu.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies